White Pine Capital’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.19M Buy
19,683
+3,248
+20% +$189K 0.34% 92
2025
Q4
$887K Buy
16,435
+640
+4% +$30.8K 0.24% 112
2025
Q3
$712K Sell
15,795
-1,210
-7% -$56.5K 0.2% 137
2025
Q2
$787K Sell
17,005
-180
-1% -$8.84K 0.25% 109
2025
Q1
$1.05M Sell
17,185
-26
-0.2% -$1.52K 0.36% 78
2024
Q4
$973K Sell
17,211
-829
-5% -$46.3K 0.33% 88
2024
Q3
$933K Sell
18,040
-2,623
-13% -$123K 0.32% 94
2024
Q2
$858K Sell
20,663
-2,606
-11% -$117K 0.33% 86
2024
Q1
$1.02M Sell
23,269
-76
-0.3% -$3.87K 0.39% 82
2023
Q4
$1.2M Sell
23,345
-6,322
-21% -$332K 0.46% 69
2023
Q3
$1.72M Sell
29,667
-285
-1% -$17.5K 0.69% 43
2023
Q2
$1.92M Sell
29,952
-334
-1% -$22.4K 0.71% 41
2023
Q1
$2.1M Sell
30,286
-220
-0.7% -$15.5K 0.82% 31
2022
Q4
$2.19M Buy
30,506
+529
+2% +$39.9K 0.86% 31
2022
Q3
$2.13M Buy
29,977
+304
+1% +$22.1K 0.89% 28
2022
Q2
$2.29M Buy
29,673
+172
+0.6% +$13.1K 0.9% 26
2022
Q1
$2.15M Buy
29,501
+3,529
+14% +$237K 0.67% 40
2021
Q4
$1.62M Buy
25,972
+3,610
+16% +$212K 0.48% 66
2021
Q3
$1.32M Hold
22,362
0.41% 84
2021
Q2
$1.52M Buy
22,362
+7,640
+52% +$498K 0.45% 77
2021
Q1
$929K Sell
14,722
-25
-0.2% -$1.55K 0.3% 110
2020
Q4
$915K Buy
14,747
+24
+0.2% +$1.48K 0.32% 99
2020
Q3
$888K Sell
14,723
-20
-0.1% -$1.2K 0.36% 81
2020
Q2
$867K Hold
14,743
0.37% 81
2020
Q1
$822K Sell
14,743
-161
-1% -$9.84K 0.42% 68
2019
Q4
$957K Sell
14,904
-2,712
-15% -$155K 0.37% 77
2019
Q3
$893K Sell
17,616
-942
-5% -$44.3K 0.33% 94
2019
Q2
$842K Sell
18,558
-9,890
-35% -$461K 0.31% 96
2019
Q1
$1.36M Sell
28,448
-2,561
-8% -$128K 0.5% 56
2018
Q4
$1.61M Sell
31,009
-228
-0.7% -$12.3K 0.66% 35
2018
Q3
$1.94M Sell
31,237
-70
-0.2% -$4.15K 0.68% 36
2018
Q2
$1.73M Sell
31,307
-725
-2% -$39.2K 0.62% 43
2018
Q1
$2.03M Sell
32,032
-10,806
-25% -$695K 0.75% 30
2017
Q4
$2.63M Buy
42,838
+1,142
+3% +$71.4K 0.96% 17
2017
Q3
$2.66K Sell
41,696
-585
-1% -$34.2K 0.01% 28
2017
Q2
$2.36M Sell
42,281
-875
-2% -$47.6K 0.93% 20
2017
Q1
$2.35M Buy
43,156
+340
+0.8% +$18.6K 0.95% 22
2016
Q4
$2.5M Buy
42,816
+448
+1% +$24.5K 1.06% 16
2016
Q3
$2.28M Sell
42,368
-95
-0.2% -$6.1K 0.97% 22
2016
Q2
$3.12M Sell
42,463
-915
-2% -$64.7K 1.31% 10
2016
Q1
$2.77M Sell
43,378
-247
-0.6% -$15.6K 1.19% 11
2015
Q4
$3M Sell
43,625
-88
-0.2% -$5.82K 1.33% 11
2015
Q3
$2.59M Buy
43,713
+7
+0% +$444 1.2% 13
2015
Q2
$2.91M Sell
43,706
-7,505
-15% -$495K 1.25% 13
2015
Q1
$3.3M Sell
51,211
-10,965
-18% -$686K 1.34% 10
2014
Q4
$3.67M Sell
62,176
-2,322
-4% -$131K 1.24% 10
2014
Q3
$3.3M Sell
64,498
-200
-0.3% -$9.99K 1.13% 17
2014
Q2
$3.14M Sell
64,698
-1,710
-3% -$84.3K 1.08% 17
2014
Q1
$3.45M Buy
66,408
+100
+0.2% +$5.32K 1.18% 14
2013
Q4
$3.52M Sell
66,308
-10,222
-13% -$521K 1.24% 12
2013
Q3
$3.54M Sell
76,530
-7,200
-9% -$316K 1.22% 16
2013
Q2
$3.74M Buy
+83,730
New +$3.64M 1.3% 12

Other funds holding BMY

White Pine Capital's BMY Position: Q1 2026 in Review

White Pine Capital increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $189K and bringing the position to 19,683 shares worth $1.19M. The position accounts for 0.34% of the portfolio, ranked #92.

White Pine Capital first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.74M in Q2 2013. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • White Pine Capital held 19,683 shares of Bristol-Myers Squibb worth $1.19M as of Q1 2026.
  • White Pine Capital bought 3,248 Bristol-Myers Squibb shares in Q1 2026, an estimated $189K.
  • Bristol-Myers Squibb made up 0.34% of White Pine Capital's portfolio in Q1 2026, its #92 holding.
  • White Pine Capital first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • White Pine Capital's Bristol-Myers Squibb position peaked at $3.74M in Q2 2013.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on White Pine Capital's 13F filing for Q1 2026, filed 11 May 2026.